Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert

Arthritis&Rheumatology,Volume 0, Issue ja, -Not available-.

Source: Arthritis and Rheumatology - June 5, 2018 Category: Rheumatology Authors: Hyon Choi , Tuhina Neogi , Lisa Stamp , Nicola Dalbeth , Robert Terkeltaub Source Type: research